C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2001
12/20/2001	US20010053364 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins
12/20/2001	US20010053361 Immunotherapy involving cd28 stimulation
12/20/2001	US20010053358 Growth differentiation factor-11
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	DE10037272A1 Identifying agents for treating cardiovascular disease, comprises determining the ability of potential agents to modify interaction between beta3 endonexin and beta3 integrin
12/20/2001	DE10028901A1 New human gene hEDG-8 encoding G-protein coupled receptor, useful for developing treatments and diagnoses for e.g. multiple sclerosis
12/20/2001	DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence
12/20/2001	DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase
12/20/2001	DE10019058A1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
12/20/2001	CA2736957A1 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
12/20/2001	CA2415319A1 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore
12/20/2001	CA2413160A1 Human tumor necrosis factor delta and epsilon
12/20/2001	CA2413077A1 Interferon for treatment of multiple sclerosis
12/20/2001	CA2413013A1 Novel motor proteins and methods for their use
12/20/2001	CA2413003A1 Immunoassays for anti-hcv antibodies
12/20/2001	CA2412821A1 Plant-signalling ligand like proteins
12/20/2001	CA2412665A1 Scramblase 2
12/20/2001	CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
12/20/2001	CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001	CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki)
12/20/2001	CA2412457A1 Modulation of abscisic acid signal transduction in plants
12/20/2001	CA2412356A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	CA2412343A1 Immunization through oral administration of a vaccine with an edible product
12/20/2001	CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
12/20/2001	CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2411965A1 The use of plant oil-bodies in vaccine delivery systems
12/20/2001	CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411401A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/20/2001	CA2411346A1 Biosynthetic oncolytic molecules and uses therefor
12/20/2001	CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2411231A1 Codon optimised recombinant dermaphagoides allergens
12/20/2001	CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions
12/20/2001	CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides
12/20/2001	CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	CA2410229A1 Vaccine for congenital tremors in pigs
12/19/2001	EP1164374A1 Method for identifying apoptosis-modified proteins
12/19/2001	EP1164195A2 Adeno-associated virus with inverted terminal repeat sequences as promoter
12/19/2001	EP1164193A1 Plant-signalling ligand like proteins
12/19/2001	EP1164191A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3
12/19/2001	EP1164190A1 Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
12/19/2001	EP1164144A1 Insulin receptor-related receptor binding protein and utilization of the same
12/19/2001	EP1164143A1 Process for preparing octreotide and derivatives thereof
12/19/2001	EP1164142A1 Novel proteins and uses thereof
12/19/2001	EP1163911A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds
12/19/2001	EP1163844A1 Transgenic mollusc and method for constructing the same
12/19/2001	EP1163639A1 Protein modeling tools
12/19/2001	EP1163524A2 Methods of screening for colorectal cancer modulators
12/19/2001	EP1163522A1 Method for detecting superantigen activity in a biological sample
12/19/2001	EP1163521A2 Assays, methods and means
12/19/2001	EP1163516A1 Effect of brefeldin a on antigen-presenting cells
12/19/2001	EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
12/19/2001	EP1163374A2 Arrays of organic compounds attached to surfaces
12/19/2001	EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors
12/19/2001	EP1163353A2 Maize ku80 homolog and uses thereof
12/19/2001	EP1163352A1 Transgenic plants that are resistant to a broad spectrum of pathogens
12/19/2001	EP1163351A1 Chimeric promoters based on the plastocyanin pete promoter from pea
12/19/2001	EP1163349A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
12/19/2001	EP1163348A1 Inducible comtii promoter, chimera gene containing same and transformed plants
12/19/2001	EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same
12/19/2001	EP1163345A1 Fungal beta-tubulin genes
12/19/2001	EP1163344A1 Hyphal growth in fungi
12/19/2001	EP1163343A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
12/19/2001	EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/19/2001	EP1163340A1 Compositions and methods for the modification of gene expression
12/19/2001	EP1163339A1 A polypeptide structure for use as a scaffold
12/19/2001	EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS
12/19/2001	EP1163337A2 Vascular adhesion molecules and modulation of their function
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163330A1 Detection, cloning and sequencing of polypeptides which drive the subcellular localization of proteins
12/19/2001	EP1163325A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources
12/19/2001	EP1163272A1 Antibodies specific for cyp1b1
12/19/2001	EP1163270A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
12/19/2001	EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
12/19/2001	EP1163268A1 Ion exchange chromatographic separation of glp-1 and related peptides
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
12/19/2001	EP1163261A1 Ion exchange chromatography of proteins and peptides with an organic modifier in the elution step
12/19/2001	EP1163260A1 Process for partitioning of proteins
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163254A2 Trpm-2 antisense therapy
12/19/2001	EP1163253A2 Syndesmos and uses thereof
12/19/2001	EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/19/2001	EP1163211A1 Method for acylating peptides and novel acylating agents
12/19/2001	EP1163000A2 Vaccine against antigens from bacteriae
12/19/2001	EP1162999A2 Vaccine against Streptococcus pneumoniae
12/19/2001	EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
12/19/2001	EP1162997A2 Staphylococcus antigen and vaccine
12/19/2001	EP1162993A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
12/19/2001	EP1162992A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
12/19/2001	EP1162983A1 Vaccine for house dust mite allergen using naked plasmid dna
12/19/2001	EP1162880A1 Human sperm surface antigens
12/19/2001	EP1162879A2 Synthesis of the first paramagnetic and active analogue (epm-2) of the melanocyte stimulating hormone containing amino acid-type stable free radical
12/19/2001	EP1162875A2 Plants transformed with thioredoxin
12/19/2001	EP1001990A4 Protein that binds trail
12/19/2001	EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof

1 ... 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 ... 2916